Mark J. Vignola, Chief Financial Officer at Terns Pharmaceuticals, Inc. (TERN), sold 26,247 shares at $5.80 ($152K) on 2025-01-06, disclosed to the SEC on 2025-01-06.
Scheduled sale ($152k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.72 | 8,129 | $46K | 30.7% |
| 2 | $5.80 | 9,059 | $53K | 34.7% |
| 3 | $5.80 | 9,059 | $53K | 34.7% |
| Total | $5.78 avg | 26,247 | $152K | 100% |
| Filing → |
| TERN | BUY | 2023-12-04 | $3K | — | Filing → |
| TERN | BUY | 2023-06-02 | $14K | — | Filing → |
| TERN | BUY | 2023-02-03 | $4 | — | Filing → |